Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Angioedema Attack”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT06806657
What this trial is testing

Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab

Who this might be right for
Hereditary Angioedema
CSL Behring 18
Testing effectiveness (Phase 2)Study completedNCT02870972
What this trial is testing

Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
BioCryst Pharmaceuticals 75
Large-scale testing (Phase 3)Study completedNCT06343779
What this trial is testing

Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+11 more
Pharvaris Netherlands B.V. 134
Large-scale testing (Phase 3)Looking for participantsNCT07266805
What this trial is testing

Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency

Who this might be right for
Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)
Pharvaris Netherlands B.V. 48
Testing effectiveness (Phase 2)Study completedNCT01359969
What this trial is testing

Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients

Who this might be right for
Hereditary Angioedema
Pharming Technologies B.V. 57
Not applicableApproved For MarketingNCT06628713
What this trial is testing

Treatment of Angioedema Attacks in Adolescent and Adult Patients 12 Years and Older With HAE Type I or II With Sebetralstat

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd.
Large-scale testing (Phase 3)Study completedNCT04656418
What this trial is testing

CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks

Who this might be right for
Hereditary Angioedema
CSL Behring 64
Large-scale testing (Phase 3)Enrolling By InvitationNCT05396105
What this trial is testing

Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+14 more
Pharvaris Netherlands B.V. 150
Large-scale testing (Phase 3)Study completedNCT02586805
What this trial is testing

Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Who this might be right for
Hereditary Angioedema (HAE)
Shire 125
Large-scale testing (Phase 3)Study completedNCT00097695
What this trial is testing

Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema

Who this might be right for
Angioedema
Shire 84
Post-approval studies (Phase 4)Study completedNCT01679912
What this trial is testing

A Call Center During HAE Attacks (SOS HAE)

Who this might be right for
Hereditary Angioedema
Assistance Publique - Hôpitaux de Paris 200
Large-scale testing (Phase 3)Study completedNCT00438815
What this trial is testing

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
Shire 113
Large-scale testing (Phase 3)Study completedNCT04070326
What this trial is testing

Lanadelumab to Prevent Hereditary Angioedema (HAE) Attacks in Children

Who this might be right for
Hereditary Angioedema
Shire 21
Large-scale testing (Phase 3)Study completedNCT01188564
What this trial is testing

Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks

Who this might be right for
Hereditary Angioedema
Pharming Technologies B.V. 75
Testing effectiveness (Phase 2)Study completedNCT03240133
What this trial is testing

Study of BCX7353 as a Treatment for Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
BioCryst Pharmaceuticals 58
Testing effectiveness (Phase 2)Study completedNCT04208412
What this trial is testing

A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 84
Large-scale testing (Phase 3)Study completedNCT04739059
What this trial is testing

Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks

Who this might be right for
Hereditary Angioedema
CSL Behring 171
Large-scale testing (Phase 3)Study completedNCT05505916
What this trial is testing

An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 145
Large-scale testing (Phase 3)Study completedNCT03873116
What this trial is testing

Study to Evaluate the Efficacy and Safety of BCX7353 as an Oral Treatment for the Prevention of HAE Attacks in Japan

Who this might be right for
Hereditary Angioedema, HAE
BioCryst Pharmaceuticals 19
Large-scale testing (Phase 3)Study completedNCT01005888
What this trial is testing

C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
Shire 26
Next Page